Children account for between 15 - 20 % of all imported
malaria cases worldwide. Immigrant children visiting their families in the country of origin in sub-Saharan Africa are at highest risk. Prevention of
malaria in children who travel to endemic areas is guided by the ABCD principles - Awareness of risk,
Bite prevention,
Chemoprophylaxis for high risk areas and rapid Diagnosis and treatment when
malaria is suspected. The use of
anti-malarial medication in small children is hampered by a paucity of dosage, pharmcokinetic and tolerability data. In the pre-travel consultation parents should be provided with practical advice on anti-mosquito measures, exact, (weight-based) dosages of
chemoprophylaxis medication and/or stand-by treatment as indicated. A paediatric formulation is available for daily
atovaquone-proguanil chemoprophylaxis (children > 11 kg) and
mefloquine is a cost-effective, once weekly prophylaxis that is useful for children > 5 kg who travel for longer periods. The bitter taste of
mefloquine should be disguised to increase adherence. When a Stand-by
Emergency Treatment (SBET) is indicated,
artemether-lumefantrine cherry flavoured dispersible
tablets are a good choice for small children. Post-travel to endemic areas,
malaria should always be suspected if a child becomes ill. Paediatric
malaria is an emergency requiring prompt diagnosis and appropriate treatment.